Skip to content
Home
Team
Portfolio
News
TCG News
Portfolio News
Careers
Contact
Menu
Home
Team
Portfolio
News
TCG News
Portfolio News
Careers
Contact
eFFECTOR Therapeutics Provides Positive Clinical Data Update for Zotatifin and General Corporate Update
Portfolio News
January 5, 2023
Prev
Previous
Remix Therapeutics Appoints Christopher Bowden, M.D., as Chief Medical Officer
Next
Carmot Therapeutics Launches Spin-Off, Kimia Therapeutics, to Focus on Metabolic Disease
Next
Scroll to Top
